Despite reduced levels of peripheral TRP, the central levels of TRP do not appear to be affected by IFN-a treatment (Raison et al., 2010), raising the possibility that neurotoxic end-products rather than serotonin play a role in the pathology of depression. The gene discussed is IFNA1; the disease is depressive symptom measurement.